Bladder Cancer

Anderson, Christopher, et al. "A 10-item checklist improves reporting of critical procedural elements during transurethral resection of bladder tumor." The Journal of urology 196.4 (2016): 1014-1020.


Sylvester, Richard J., et al. "Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials." European urology 49.3 (2006): 466-477.

Finding the Bladder Cancer

Bladder Cancer Risk Factors

Presentation

Obtaining Bladder Cancer Diagnosis

TURBT Tips

Post-TURBT intravesical chemotherapy

When to repeat TURBT (within 4-6 weeks)

Is Workup needed for UTUC?

NMIBC vs MIBC

Chang, Sam S., et al. "Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline." The Journal of urology 196.4 (2016): 1021-1029.

Non-Muscle Invasive Bladder Cancer

Low risk recommendations

Intermediate risk recommendations

High risk recommendations

What to do with NMIBC recurrence

Variant Histology: what it is, and what to do

Intravesical Chemotherapy (+ BCG)

Bacillus Calmette–Guerin (BCG)

Mitomycin (MMC)

Doxorubicin/Epirubicin

Muscle Invasive Bladder Cancer

Diagnosed...now what?

Neoadjuvant Chemotherapy

Cystectomy

Considerations

Are there alternatives to cystectomy? Enter bladder preservation

Which urinary diversion should be used?

Surgical Risks/Expectations

Surgical Optimization

Post-Cystectomy prognosis

Sources